SynbiCITE sponsors new award for synthetic biology
- Posted on 2 October, 2015
SynbiCITE is proud to be the first sponsor of the new OBN Award for Best Emerging UK SynBio Company.
The winner is Oxitec and the award was announced last night, Thursday 1st October at the Ashmolean Museum in Oxford. Oxitec won the award for developing pioneering solutions to control insects that spread human disease and damage crops.
Dr Steve Chambers, CEO of SynbiCITE said “All the SynBio companies at the OBN awards, nominees and winners, represent the very best of synthetic biology in the UK. We are privileged to be able help them work towards commercialisation of ground breaking and disruptive technology.
SynbiCITE partner Touchlight Genetics won the award for Best Emerging UK Biotech Company.
You can find out more about the event and details of all last night's winners on OBN's website.
Share this article:
People also read
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform
CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scala...
Biotech firm MiAlgae secures £1m to turn whisky by-products into pet and fish food
An Edinburgh-based biotech startup which turns whisky distillation by-products into pet and fish food has received investment of £1 million.MiAlgae pr...